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The criteria that need to be fulfilled before regarding a mycoplasma as a cause of non-
gonococcal urethritis (NGU) are outlined. Of the seven mycoplasmas that have been isolated
from the human genitourinary tract, most cannot be considered as contenders for causing
NGU. Although there is no evidence to support an etiological role for Mycoplasma hominis, it
may be unwise to ignore this mycoplasma in view of its known pathogenicity in other situa-
tions. The cumulative weight of evidence indicates that strains of Ureaplasma urealyticum
(ureaplasmas) cause NGU in some patients. The reason for their occurrence in the urethra of
some men without disease needs to be established. Ureaplasmas do not seem to cause post-
gonococcal urethritis. The role in NGU of M. genitalium, newly discovered in the male
urethra, is unknown, but its biological features, morphological appearance, and ability to
cause genital disease in marmosets suggest that it may be pathogenic for man.
There have been several publications recently in which the part played by
mycoplasmas in human disease [1] and, particularly, in genitourinary disease [2-4]
has been reviewed. In this communication the role ofmycoplasmas in the etiology of
non-gonococcal urethritis (NGU) is discussed.
OCCURRENCE OF MYCOPLASMAS IN THE GENITOURINARY TRACT
Twelve mycoplasma species constitute the normal flora or are pathogens of
humans. Nine of these mycoplasmas have been found in the respiratory tract and
seven in the genitourinary tract (Table 1), four having been isolated from both
anatomical sites. Because Mycoplasma hominis and Ureaplasma urealyticum
organisms (ureaplasmas) are found frequently in the genitourinary tract, especially
in disease, they are the main mycoplasmal candidates for causing NGU.
CRITERIA FOR ESTABLISHING THAT A MYCOPLASMA IS A CAUSE OF
DISEASE
To establish a causal relationship between mycoplasmal infection and disease it is
necessary to demonstrate that (i) the organisms are isolated more frequently and/or in
larger numbers from patients with disease than from those without; (ii) antibody
responses, measured by any of several available techniques, occur in patients with
disease; (iii) the organisms disappear and the disease responds to treatment with an-
timicrobial agents to which the organisms are susceptible in vitro; and (iv) the
organisms infect an animal host from which they can be recovered and, in so doing,
produce disease similar to that seen in man; in other words, there should be fulfil-
ment of Koch's postulates.
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TABLE I
The Metabolism, Occurrence, and Disease Association of Mycoplasmas Isolated
from the Human Genitourinary Tract
Frequency of Isolation from the
Metabolism Genitourinary Respiratory Cause of
Mycoplasma of Tract Tract Rectum Eye Blood Disease
M. fermentans Glucose and Rare - - - - No
Arginine
M. genitalium Glucose ? ? ? ? ? ?
M. hominis Arginine Common Rare Common Rare Very rare Yes
M. pneumoniae Glucose Very rare Rare' _ _ - Yes
M. primatum Arginine Rare - - - - No
M. salivarium Arginine Rare Common - - - No
U. urealyticum Urea Common Rare Common Rare Very rare Yes
aExcept in disease outbreaks
ROLE OF LARGE-COLONY-FORMING MYCOPLASMAS IN THE
ETIOLOGY OF NGU
Isolation Studies
After large-colony-forming mycoplasmas were first isolated from the male
urethra, there have been numerous studies designed to determine whether they are a
cause of NGU. The results of studies in which the frequency of isolation from men
with NGU was compared with that from apparently healthy men have been sum-
marized previously [5]. Although confusion may still exist about the interpretation
of the various results, it is quite clear that M. fermentans and M. primatum cannot
be considered as significant causes of NGU because they are isolated so rarely from
the genitourinary tract in either health or disease. Most of the mycoplasmas, par-
ticularly in the early studies, were not identified, but it is likely that the majority of
them were M. hominis. If this is so, when the studies are viewed as a whole, there is
no difference between the frequency ofisolation ofthis mycoplasma from men with
disease and from apparently healthy men. However, if the studies are considered
separately [6], there are considerable differences in the results, probably because the
criteria for selecting cases of NGU differed widely. These differences were sup-
ported by differences in the prevalence ofcomplement-fixing antibody in thevarious
groups [7]. This disparity in isolation rate and antibody prevalence between the
NGU group and the so-called control group led to the belief that M. hominis was of
etiological importance. However, when control groups more comparable to the pa-
tient group were studied, the difference in isolation rates was less apparent [2,8,9].
Indeed, some workers [10,11] have isolated M. hominis more frequently from per-
sons without urethritis than from those suffering from NGU. More recently, Bowie
and colleagues [12,13] examined patients without urethritis and those suffering from
NGU, dividing the latter into chlamydia-positive and chlamydia-negative groups.
M. hominis was isolated from the first-voided urine in 19-22 percent of men in all
the groups, which did not lead these investigators to believe that it was a cause of
disease. It is hardly surprising that interpretation ofthe results ofmost studies is dif-
ficult or impossible when the majority ofworkers have been unable or failed to take
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into account the possible role of other potential NGU-producing microorganisms,
particularly chlamydiae.
Antibiotic Studies
The response of patients to antibiotics, including those which differentiate be-
tween M. hominis and some other microorganisms, has been difficult to interpret.
Erythromycin was found to be effective in the treatment of NGU [14,15], although
M. hominis is resistant to this antibiotic in vitro. This, however, does not mitigate
against a role for M. hominis in NGU because the major clinical response may have
been due to the effect of erythromycin on ureaplasmas and chlamydiae. In another
study [16], lincomycin, which inhibits M. hominis in vitro, was found to be more ef-
fective than a placebo in treating the disease but may also have inhibited chlamydiae
which were not sought. Coufalik and colleagues [17] gave rifampicin, which is active
against chlamydiae in vitro but ineffective against both M. hominis and urea-
plasmas, to men who had NGU. Although the study was not designed to investigate
whether M. hominis was pathogenic, the results were not consistent with this view.
Undertaking a placebo-controlled antibiotic study in which only M. hominis-
positive NGU cases are included would seem to be the best approach to help support
or refute this suggestion.
ROLE OF UREAPLASMA UREALYTICUM
As mentioned previously, the problem in all studies concerned with the etiology of
genitourinary diseases is that mycoplasmas are not the only contenders. Chlamydial
infection causes probably 50 percent of cases of NGU, so that the question arises of
whether ureaplasmal infection accounts for all, or part, ofthe remainder. The extent
to which the requirements for incriminating amycoplasma as acause ofdisease have
been fulfilled in the case of ureaplasmas and NGU is outlined in Table 2. Some
aspects which have not been helpful in defining this relationship have been discussed
before [27]. It is worth drawing attention to two recent observations. The first con-
cerns the detection of ureaplasmal antibody by an ELISA technique which has
broad serotype cross-reactivity; a significant change in antibody levels for one or
more antibody classes was detected in the sera of 12 (67 percent) of 18 NGU pa-
tients, and ten (83 percent) of the 12 individuals had a change in the IgM class sug-
gestive of an active infection [20]. This was more than had been seen in previous
studies where the metabolism-inhibition technique had often been used with a few
serotypes only; because of its serotype specificity this procedure would not have
been expected to detect more than a small proportion of responses, and IgM an-
tibody would not have been sought. The second observation concerns ureaplasmal
infection ofthe urethra of a 23-year-old hypogammaglobulinemic male patient [19].
He developed a chronic urethral discharge from which . 5 x 108 ureaplasmas, but
not chlamydiae, were isolated. This is about 100-fold more than the number of
ureaplasmas expected in men with urethritis, and in such profusion they were prob-
ably responsible for his disease. He did not respond clinically to any antibiotics since
the organisms were resistant or developed resistance to all of them, including the
tetracyclines.
It is clear from the data presented in Table 2 that most of the criteria required for
regarding ureaplasmas as a cause of NGU have been met, and it does not seem
reasonable to take the view that the results of all the studies are entirely false. It
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TABLE 2
Reasons for Incriminating Ureaplasmas as a Cause of NGU
Study and Result Comment Reference
Isolation
a. Qualitative:
Recovery more often from
patients with NGU than from
controls
b. Quantitative:
104 or more organisms asso-
ciated with tetracycline-
responsive disease
c. 5 x 108 organsims and
chronic urethral discharge in
hypogammaglobulinemia
2. Antibody response in patients
with disease
But in half the studies only
Chlamydiae not isolated
In a small proportion of patients
only in most studies
In >50 percent of patients by
ELISA
3. Response to antibiotics
a. Suboptimal tetracyclines:
Disappearance of disease and
organisms, followed by clinical
relapse and return of organisms
b. Minocycline versus placebo:
Greater response of urea-
plasma-positive only NGU to
minocycline
c. Antibiotics which differentiate
between ureaplasmas and
chlamydiae: Response of
ureaplasma-positive only NGU
to antibiotic selectively in-
hibiting ureaplasmas; failure
to respond to non-inhibitory
drugs
d. Tetracycline-resistant urea-
plasmas:
No clinical response until
erythromycin given
4. Intraurethral inoculation of
human volunteers:
Development of disease, recovery
of organisms, and response to
treatment
5. Intraurethral inoculation of
chimpanzees:
Infection but no disease by
multiple-passaged organisms;
disease produced by unpassaged
organisms
Chlamydiae not considered
Chlamydiae not considered
[25]
[26]
[Taylor-Robinson et al:
unpublished observations]
1.
[4]
[181
[19]
[4]
[20]
[21]
[22]
[23]
[17]
[24]
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seems more rational to believe that the cumulative data are indicative of a
pathogenic role for ureaplasmas in the male genital tract.
Ureaplasmas in Men Who Do Not Have Urethritis
If ureaplasmas are a cause of NGU, an explanation is required for their recovery
so often from men who do not have urethritis. Several possibilities exist. It may be
that (i) only certain ureaplasma serotypes are pathogenic. Serotype 4 was recovered
in one study twice as frequently from men with NGU as from those who were
symptom-free [21]. There may be grounds for believing, therefore, that serotypes
are important but pathogenic and non-pathogenic strains could belong to a single
serotype. (ii) Ureaplasmas involve only the prepuce and meatus in a non-disease-
producing capacity but under some circumstances invade the urethra to cause NGU.
Procedures have not, so far, distinguished between the different sites ofcolonization
or infection in men with and without disease. (iii) Ureaplasmas produce NGU which
resolves spontaneously, but the organisms then persist. (iv) Ureaplasmas produce
NGU but those within the prostate and para-urethral glands are not always
eliminated by treatment. These do not cause subsequent disease but are sometimes
detected in the urethra. (v) Ureaplasmas cause only the first or early episodes of
NGU, later encounters resulting in colonization without urethritis.
POST-GONOCOCCAL URETHRITIS (PGU)
PGU would seem to be caused mainly by chlamydiae [28]. Although there is
evidence that ureaplasmas cause some cases of NGU, evidence that they cause any
cases of PGU is lacking. The results of an early quantitative study [8] failed to sug-
gest an association between ureaplasmas and PGU but could have been misleading
because chlamydiae were not investigated. However, when these organisms were
taken into account [29] an association was still not detected. In a study by Bowie
and colleagues [30], PGU was significantly associated with chlamydial infection
(p < 0.02) among men who were not colonized by ureaplasmas; among men with
chlamydial infections, PGU developed in 11 (61 percent) of 18 men who had a
ureaplasmal infection and five (28 percent) of 18 who did not (p = 0.09). This may
suggest that the ureaplasmas potentiated the chlamydial infections, but supportive
data are required.
ROLE OF A NEWLY DISCOVERED MYCOPLASMA
Some patients suffering from NGU, and from whom ureaplasmas, mycoplasmas,
and chlamydiae cannot be isolated, respond to tetracycline therapy. This has suggested
that another tetracycline-sensitive microorganism might be responsible for these
cases. In this context, the isolation of a glucose-metabolizing mycoplasma from the
genitourinary tract of two of 13 men with NGU by means of a special culture
medium (SP4) is of interest [31,32]. The strains G37 and M30 are closely related to
each other and are different serologically from all other known mycoplasmas, thus
constituting a new species which has been named M. genitalium [33]. The organisms
adhere to glass and plastic, erythrocytes, and monkey kidney cells. This property ap-
pears to be associated with surface material restricted to the area of a terminal struc-
ture ofthe flask-shaped mycoplasmas. Although there are insufficient data to relate
this new mycoplasma to NGU or other genitourinary infections, its isolation in
special medium, specialized structure, capacity to adhere to cells, and ability to pro-
duce an inflammatory cell response in the vagina of marmosets, accompanied by an
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antibody response [34] indicate that it has pathogenic potential; its presence in the
urethra of patients with NGU suggests that it could be implicated in the disease.
CONCLUSIONS AND PROPOSALS
The overall impression is that M. hominis is not a cause ofNGU. However, subse-
quent to the isolation of U. urealyticum, this large-colony-forming mycoplasma has
been almost totally ignored. It may be prudent to consider it as a candidate for caus-
ing some cases of NGU because of its known ability to cause postpartum and
postabortal fever and acute salpingitis. The relevance of studies based on differen-
tial antibiotic therapy undertaken so far is dubious. They would be unlikely to lead
to the recognition of a small contribution byM. hominis, particularly as chlamydiae
were not taken into consideration. The best approach would be to design a study in
which a group of NGU patients infected with M. hominis and ureaplasmas but not
chlamydiae were treated with lincomycin, an inhibitor of M. hominis but not
ureaplasmas, and a similar group ofpatients were treated with erythromycin, which
has the reverse effect. Further approaches worthy of consideration in evaluating a
possible role ofM. hominis in NGU are serological evaluations based, particularly,
on the ELISA technique, and experimental intraurethral inoculation of male chim-
panzees with strains, possibly those that have spread hematogenously, which have
had few passes in medium.
It is not possible to predict which of the explanations, if any, for ureaplasmas oc-
curring in men without urethritis is most likely to be correct and, of course, they
may not be mutually exclusive. It is clear, however, that studies should be designed
to resolve the situation and that these must take into account all potential
pathogenic microorganisms, not just ureaplasmas, and be quantitative rather than
qualitative in nature. In the meantime, it is important to emphasize that there is no
virtue in attempting to isolate ureaplasmas from patients with NGU on a routine
basis since positive results, so easy to obtain, do not enable the clinician to know
whether the organisms are unequivocally a cause of the diseases.
In the case of M. genitalium, efforts to define its distribution and relation to
disease are in progress. A study of experimentally inoculated marmosets revealed
that serum antibody was best detected by an immunofluorescence technique. It is
clear that this technique, among others, should be used in attempts to detect an-
tibody responses in men with NGU. Furthermore, although the pathogenicity ofthis
mycoplasma has been demonstrated in female marmosets, the relevance of the
microorganism to NGU would be better satisfied by undertaking studies in male
chimpanzees.
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